Reifart Joerg, Schilling Konstanze, Hamm Christian W, Reifart Nicolaus
Department of Cardiology, Kerckhoff Heart and Thorax Center, Benekestr. 2-8, 61231, Bad Nauheim, Germany.
DZHK (German Center for Cardiovascular Research), partner site Rhein-Main, Frankfurt am Main, Germany.
Egypt Heart J. 2021 Feb 5;73(1):14. doi: 10.1186/s43044-021-00134-z.
Percutaneous interventions to address chronic coronary occlusions (CTO-PCI) often require simultaneous ipsi- and contralateral coronary injections. Although radial access is increasingly popular, bifemoral artery access is still the preferred choice of CTO operators. The aim of this case series is to demonstrate the feasibility and safety of the unifemoral parallel sheath technique, which avoids two puncture sites, increases patient comfort, and improves procedure ergonomics. It offers rapid second access to the femoral artery adjacent to the first sheath as well as closure by unilateral manual compression without or with 1 or 2 vascular closure devices.
We retrospectively evaluated the procedure results in 90 consecutive CTO patients where an ipsilateral parallel sheath access was considered. Placement of the second sheath uneventfully failed in two because of severe femoral calcification and narrowing. In 96.6%, the first sheath was 7 F (3.4% 6F), while the second sheath was 4 F in 22.7%, 5 F in 64.7%, and 6 or 7 F in 11.4% each. No major complications nor severe bleeding events occurred, and the mean drop of hemoglobin was low (0.6 g/dL ± 0.86).
In CTO-PCI requiring contralateral coronary injections or the retrograde technique, the ipsilateral parallel sheath technique might be a feasible alternative to the standard bifemoral or femoral-radial access.
经皮介入治疗慢性冠状动脉闭塞病变(CTO-PCI)通常需要同时进行同侧和对侧冠状动脉注射。尽管桡动脉入路越来越受欢迎,但双侧股动脉入路仍是CTO介入操作者的首选。本病例系列的目的是证明单股平行鞘技术的可行性和安全性,该技术避免了两个穿刺部位,提高了患者舒适度,并改善了操作的人体工程学。它能快速获得与第一个鞘相邻的股动脉的二次入路,并且可通过单侧手动压迫(有无1或2个血管闭合装置)实现闭合。
我们回顾性评估了90例连续的CTO患者的手术结果,这些患者均考虑采用同侧平行鞘入路。由于严重的股动脉钙化和狭窄,有2例患者的第二个鞘置入未成功。在96.6%的患者中,第一个鞘为7F(3.4%为6F),而第二个鞘为4F的占22.7%,5F的占64.7%,6F或7F的各占11.4%。未发生重大并发症或严重出血事件,血红蛋白平均下降幅度较低(0.6 g/dL±0.86)。
在需要对侧冠状动脉注射或逆行技术的CTO-PCI中,同侧平行鞘技术可能是标准双侧股动脉或股动脉-桡动脉入路的可行替代方案。